Medtronic Launches Smart Insulin Pen with Real-Time CGM Data For People on Multiple Daily Injections

Medtronic InPen CGM Data
Image: Companion Medical

Medtronic has launched InPen, an FDA- cleared smart insulin pen for people on multiple daily injections (MDI). The smart insulin pen will link with the Medtech giant’s Guardian Connect continuous glucose monitoring system, to help track insulin doses alongside real-time blood sugar readings through a single smartphone app provided by Medtronic.

Related Medtronic Buys Smart Insulin Pen Company Companion Medical

The integration of real-time CGM data into the smart insulin pen app is a result of the addition of Companion Medical’s InPen to the Medtronic portfolio, as of September 2020. The acquisition enables Medtronic to serve more people — regardless of how they prefer their insulin to be delivered — and offers a unique and expansive ecosystem of support across their diabetes journey, reports Medtronic.

“We’re strongly committed to delivering solutions that make life easier for people living with diabetes. We’re pleased to build on the success of InPen with added real-time glucose data which provides a complete picture for users as they look to give themselves the right dose of insulin at the right time,” said Sean Salmon, executive vice president and president of the Diabetes Business at Medtronic. “Our successful integration of these devices in just two months following the close of our Companion Medical acquisition is a testament to the close collaboration of our employees and a strong passion to serve our customers with better solutions to manage their diabetes.”

Mobile phones

The InPen app will continue to display information from other currently compatible CGM systems on a three-hour delay.

Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.

Related Medtronic Wins FDA Clearance And CE Approval For LINQ II Insertable Cardiac Monitor

Headquartered in Dublin, Ireland, Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare further.

Previous articleWill Combined Power of 5G and Artificial Intelligence Change Tech Innovations of Tomorrow?
Next articleSafeguarding Trade Secrets Around Medical Wearables
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.